Source: Reuters
France’s Sanofi on Monday agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion as it steps up a push in the lucrative field of cancer drugs under its new chief executive.
Sign up for your daily digest of Central Pa. News.
Homes sale prices up in York-Adams, but remain affordable
18/10/2021
History-making $5M donation to Millersville University to benefit business studi[...]
20/8/2021
Elizabethtown College receives $6.5 million gift, second largest in institution[...]
25/6/2021
Ollie’s looks to hire for 2,000 positions nationwide through one-day hiring ev[...]
10/6/2021
Harrisburg Esports team to open public-facing gaming center this year
10/6/2021